Tag Archives: Teflaro

FDA approves New Antibiotic for Pneumonia and Skin Infections

The US Food and Drug Administration (FDA) approves a new injectable antibiotic, ceftaroline fosamil (Teflaro; Forest Laboratories), for treating community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin-structure infections (ABSSSI), including the methicillin-resistant Staphylococcus aureus (MRSA).  Ceftaroline is a … Continue reading

Posted in Others, Respiratory Disease | Tagged , , , , , , , , , , | Comments Off on FDA approves New Antibiotic for Pneumonia and Skin Infections